Conjugation of NaGdF4 upconverting nanoparticles on silica nanospheres as contrast agents for multi-modality imaging

Biomaterials

Volumn 34, Issue 21, 2013, Pages 5218-5225

  Liu, Fuyao ^a,d   He, Xiuxia ^a,c   Liu, Liang ^b   You, Hongpeng ^a   Zhang, Huimao ^b   Wang, Zhenxin ^a  

^a CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY   (China)

^b JILIN UNIVERSITY   (China)

^c CHANGCHUN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Contrast agents; Invivo test; Multi modality imaging; Silica nanosphere; Upconverting nanoparticle

Indexed keywords

CONTRAST AGENT; IN-VIVO TESTS; MULTI-MODALITY IMAGING; SILICA NANOSPHERES; UPCONVERTING NANOPARTICLES;

BIOLOGICAL ORGANS; COMPUTERIZED TOMOGRAPHY; CYTOTOXICITY; DOPING (ADDITIVES); ERBIUM; MAGNETIC RESONANCE; NANOPARTICLES; NANOSPHERES; SILICA;

YTTERBIUM;

CONTRAST MEDIUM; LANTHANIDE; METHYLPHOSPHONIC ACID; NANOCOMPOSITE; NANOPARTICLE; NANOSPHERE; POLOXAMER; SILICON DIOXIDE; UNCLASSIFIED DRUG; UPCONVERTING NANOPARTICLE; DIAGNOSTIC AGENT; FLUORIDE; GADOLINIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONJUGATION; CYTOTOXICITY; DIAGNOSTIC IMAGING; HISTOLOGY; IMAGE QUALITY; IN VIVO STUDY; LUMINESCENCE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; SYNTHESIS; X RAY; ANIMAL; BAGG ALBINO MOUSE; CELL DEATH; CHEMISTRY; HUMAN; METHODOLOGY; NEOPLASM; NUCLEAR MAGNETIC RESONANCE IMAGING; NUDE MOUSE; PATHOLOGY; SPECTROSCOPY; TUMOR CELL LINE; ULTRASTRUCTURE; DIAGNOSTIC USE; NEOPLASMS; PROCEDURES;

ANIMALIA;

ANIMALS; CELL DEATH; CELL LINE, TUMOR; CONTRAST MEDIA; DIAGNOSTIC IMAGING; FLUORIDES; GADOLINIUM; HUMANS; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED BALB C; MICE, NUDE; NANOSPHERES; NEOPLASMS; POLOXAMER; SILICON DIOXIDE; SPECTRUM ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84877025310     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.03.058     Document Type: Article

References (51)

1. Kobayashi H., Ogawa M., Alford R., Choyke P.L., Urano Y. New strategies for fluorescent probe design in medical diagnostic imaging. Chem Rev 2010, 110:2620-2640.
2. Zhou J., Liu Z., Li F.Y. Upconversion nanophosphors for small-animal imaging. Chem Soc Rev 2012, 41:1323-1349.
3. Rabin O., Perez J.M., Grimm J., Wojtkiewicz G., Weissleder R. An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles. Nat Mater 2006, 5:118-122.
4. Logothetis N.K. What we can do and what we cannot do with fMRI. Nature 2008, 453:869-878.
5. Louie A. Multimodality imaging probes: design and challenges. Chem Rev 2010, 110:3146-3195.
6. Xiao Q.F., Bu W.B., Ren Q.G., Zhang S.J., Xing H.Y., Chen F., et al. Large-scale radiopaque fluorescence-transparent TaOx decorated upconversion nanophosphors for invivo CT/MR/UCL trimodal imaging. Biomaterials 2012, 33:7530-7539.
7. Cheng L., Yang K., Li Y.G., Chen J.H., Wang C., Shao M.W., et al. Facile preparation of multifunctional upconversion nanoprobes for multimodal imaging and dual-targeted photothermal therapy. Angew Chem Int Ed 2011, 50:7385-7390.
8. 4:Yb, Er/Tm nanostructure for MRI, CT and upconversion luminescence tri-modality imaging. Biomaterials 2012, 33:4618-4627.
9. Huang X.L., Zhang F., Lee S., Swierczewska M., Kiesewetter D.O., Lang L.X., et al. Long-term multimodal imaging of tumor draining sentinel lymph nodes using mesoporous silica-based nanoprobes. Biomaterials 2012, 33:4370-4378.
10. Liu Y.L., Ai K.L., Liu J.H., Yuan Q.H., He Y.Y., Lu L.H. Ahigh-performance ytterbium-based nanoparticulate contrast agent for invivo X-ray computed tomography imaging. Angew Chem Int Ed 2012, 51:1437-1442.
11. Yang Y.M., Shao Q., Deng R.R., Wang C., Teng X., Cheng K., et al. Invitro and invivo uncaging and bioluminescence imaging by using photocaged upconversion nanoparticles. Angew Chem Int Ed 2012, 51:3125-3129.
12. Hinklin T.R., Rand S.C., Laine R.M. Transparent, polycrystalline upconverting nanoceramics: towards 3-D displays. Adv Mater 2008, 20:1270-1273.
13. 3:Yb/Er thin films. Angew Chem Int Ed 2011, 50:6876-6880.
14. 2 nanocomposite layer. Adv Mater 2010, 22:4373-4377.
15. Joubert M.F. Photon avalanche upconversion in rare earth laser materials. Opt Mater 1999, 11:181-203.
16. Chatterjee D.K., Gnanasammandhan M.K., Zhang Y. Small upconverting fluorescent nanoparticles for biomedical applications. Small 2010, 6:2781-2795.
17. 4 nanocrystals: syntheses and bioapplications. Nano Res 2011, 4:685-694.
18. 4-based upconversion nanophosphors with long-term validity for multimodal lymphatic imaging. Biomaterials 2012, 33:6201-6210.
19. Wang C., Tao H.Q., Cheng L., Liu Z. Near-infrared light induced invivo photodynamic therapy of cancer based on upconversion nanoparticles. Biomaterials 2011, 32:6145-6154.
20. Krämer K.W., Biner D., Frei G., Güdel H.U., Hehlen M.P., Luthi S.R. Hexagonal sodium yttrium fluoride based green and blue emitting upconversion phosphors. Chem Mater 2004, 16:1244-1251.
21. 4 upconversion nanocrystals via an oa/ionic liquid two-phase system for invivo dual-modality imaging. Adv Funct Mater 2011, 21:4470-4477.
22. 5:Yb/Er nanoprobes for multi-modal upconversion fluorescent, invivo X-ray computed tomography and biomagnetic imaging. Biomaterials 2012, 33:9232-9238.
23. Wang Y.F., Sun L.D., Xiao J.W., Feng W., Zhou J.C., Shen J., et al. Rare-earth nanoparticles with enhanced upconversion emission and suppressed rare-earth-ion leakage. Chem Eur J 2012, 18:5558-5564.
24. Li Z.Q., Zhang Y., Jiang S. Multicolor core/shell-structured upconversion fluorescent nanoparticles. Adv Mater 2008, 20:4765-4769.
25. 2 nanoparticles with ultrathin shell for biolabeling applications. Nanoscale 2013, 5:1047-1053.
26. Wang L., Yang C.Y., Tan W.H. Dual-luminophore-doped fluorescent silica nanoparticles for multiplexed signaling. Nano Lett 2005, 5:37-43.
27. Tallury P., Payton K., Santra S. Silica-based multimodal/multifunctional nanoparticles for bioimaging and biosensing applications. Nanomedicine 2008, 3:579-592.
28. Wu C.L., Zheng J.S., Huang C.B., Lai J.P., Li S.Y., Chen C., et al. Hybrid silica-nanocrystal-organic dye superstructures as post-encoding fluorescent probes. Angew Chem Int Ed 2007, 46:5393-5396.
29. Cheng L., Yang K., Shao M.W., Lee S.T., Liu Z. Multicolor invivo imaging of upconversion nanoparticles with emissions tuned by luminescence resonance energy transfer. JPhys Chem C 2011, 115:2686-2692.
30. Kim J., Lee J.E., Lee J., Jang Y., Kim S.W., An K., et al. Generalized fabrication of multifunctional nanoparticle assemblies on silica spheres. Angew Chem Int Ed 2006, 45:4789-4793.
31. Jun B.H., Hwang D.W., Jung H.S., Jang J., Kim H., Kang H., et al. Ultrasensitive, biocompatible, quantum-dot-embedded silica nanoparticles for bioimaging. Adv Funct Mater 2012, 22:1843-1849.
32. Wang F., Wang J., Liu X.G. Direct evidence of a surface quenching effect on size-dependent luminescence of upconversion nanoparticles. Angew Chem Int Ed 2010, 49:7456-7460.
33. Stöber W., Fink A., Bohn E. Controlled growth of monodisperse silica spheres in the micron size range. JColloid Interface Sci 1968, 26:62-69.
34. 4:Yb, Er@Carbon nanoparticles in water-in-oil microemulsion. JMater Res 2011, 26:82-87.
35. Westcott S.L., Oldenburg S.J., Lee T.R., Halas N.J. Formation and adsorption of clusters of gold nanoparticles onto functionalized silica nanoparticle surfaces. Langmuir 1998, 14:5396-5401.
36. 4 nanoparticles with peg-phosphate ligands for NIR (800nm) biolabeling within the biological window. Langmuir 2010, 26:1157-1164.
37. 4 (Ln=Eu, Tb, Er) multifunctional microspheres for capturing and labeling phosphopeptides. Small 2012, 8:3456-3464.
38. Bagwe R.P., Hilliard L.R., Tan W.H. Surface modification of silica nanoparticles to reduce aggregation and nonspecific binding. Langmuir 2006, 22:4357-4362.
39. 4:Yb, Er(Tm) nanoparticles in culture media for bioimaging. JMater Chem 2012, 22:18596-18602.
40. Lin J.J., Chen J.S., Huang S.J., Ko J.H., Wang Y.M., Chen T.L., et al. Folic acid-Pluronic F127 magnetic nanoparticle clusters for combined targeting, diagnosis, and therapy applications. Biomaterials 2009, 30:5114-5124.
41. Lim J.K., Majetich S.A., Tilton R.D. Stabilization of superparamagnetic iron oxide core-gold shell nanoparticles in high ionic strength media. Langmuir 2009, 25:13384-13393.
42. 3: synthesis and applications of magnetic resonance contrast agents and template particles for hollow spheres and hybrid composites. Adv Funct Mater 2008, 18:766-776.
43. 3+ up-conversion nanoprobes as high-performance contrast agents for multi-modality imaging. Biomaterials 2013, 34:1712-1721.
44. 1 MRI contrast enhancement. Chem Mater 2011, 23:3714-3722.
45. 4 nanoparticle-based molecular probes for magnetic resonance imaging of intraperitoneal tumor xenografts invivo. ACS Nano 2013, 7:330-338.
46. Zhou J., Sun Y., Du X.X., Xiong L.Q., Hu H., Li F.Y. Dual-modality invivo imaging using rare-earth nanocrystals with near-infrared to near-infrared (NIR-to-NIR) upconversion luminescence and magnetic resonance properties. Biomaterials 2010, 31:3287-3295.
47. (x) core/shell nanoparticles for simultaneous magnetic resonance imaging and X-ray computed tomography. JAm Chem Soc 2012, 134:10309-10312.
48. 3 up-conversion nanoparticle as an invivo X-ray CT imaging contrast agent. Biomaterials 2012, 33:6748-6757.
49. Kim D., Park S., Lee J.H., Jeong Y.Y., Jon S. Antibiofouling polymer-coated gold nanoparticles as a contrast agent for invivo X-ray computed tomography imaging. JAm Chem Soc 2007, 129:7661-7665.
50. Sun I.C., Eun D.K., Na J.H., Lee S., Kim I.J., Youn I.C., et al. Heparin-coated gold nanoparticles for liver-specific CT imaging. Chem Eur J 2009, 15:13341-13347.
51. Cheng L., Yang K., Shao M.W., Lu X.H., Liu Z. Invivo pharmacokinetics, long-term biodistribution and toxicology study of functionalized upconversion nanoparticles in mice. Nanomedicine 2011, 6:1327-1340.